Home

Energizar Criação Magnético nature medicine acceptance rate menor Hesitar Extensivamente

About Scientific Reports | Scientific Reports
About Scientific Reports | Scientific Reports

AI in health and medicine | Nature Medicine
AI in health and medicine | Nature Medicine

Nature Communications
Nature Communications

Reporting guideline for the early-stage clinical evaluation of decision  support systems driven by artificial intelligence: DECIDE-AI | Nature  Medicine
Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI | Nature Medicine

Individual and community-level risk for COVID-19 mortality in the United  States | Nature Medicine
Individual and community-level risk for COVID-19 mortality in the United States | Nature Medicine

The next generation of evidence-based medicine | Nature Medicine
The next generation of evidence-based medicine | Nature Medicine

Single-cell multi-omics analysis of the immune response in COVID-19 | Nature  Medicine
Single-cell multi-omics analysis of the immune response in COVID-19 | Nature Medicine

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based  biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine

Modeling transmission of SARS-CoV-2 Omicron in China | Nature Medicine
Modeling transmission of SARS-CoV-2 Omicron in China | Nature Medicine

Nature Medicine
Nature Medicine

Nature (journal) - Wikipedia
Nature (journal) - Wikipedia

Nature Medicine - Wikipedia
Nature Medicine - Wikipedia

Long COVID in a prospective cohort of home-isolated patients | Nature  Medicine
Long COVID in a prospective cohort of home-isolated patients | Nature Medicine

Federated learning for predicting clinical outcomes in patients with  COVID-19 | Nature Medicine
Federated learning for predicting clinical outcomes in patients with COVID-19 | Nature Medicine

Multimodal biomedical AI | Nature Medicine
Multimodal biomedical AI | Nature Medicine

Journal Metrics | Nature Portfolio
Journal Metrics | Nature Portfolio

Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA  neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial  interim results | Nature Medicine
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results | Nature Medicine

🏆 Nature Medicine | Impact Factor | Indexing | Acceptance rate |  Abbreviation - Open access journals
🏆 Nature Medicine | Impact Factor | Indexing | Acceptance rate | Abbreviation - Open access journals

Open access at the Nature Portfolio | Nature Portfolio
Open access at the Nature Portfolio | Nature Portfolio

Jason Sheltzer on Twitter: "If you choose to transfer a manuscript between  Nature-family journals, you can consult a web page that lists the acceptance  rates for 124 journals published by the Springer
Jason Sheltzer on Twitter: "If you choose to transfer a manuscript between Nature-family journals, you can consult a web page that lists the acceptance rates for 124 journals published by the Springer

Open access: The true cost of science publishing | Nature
Open access: The true cost of science publishing | Nature

Journal Metrics | Nature Portfolio
Journal Metrics | Nature Portfolio

A guide to immunotherapy for COVID-19 | Nature Medicine
A guide to immunotherapy for COVID-19 | Nature Medicine

Volume 25 | Nature Medicine
Volume 25 | Nature Medicine

npj Genomic Medicine
npj Genomic Medicine

PDF] Acceptance rates of scholarly peer-reviewed journals: A literature  survey | Semantic Scholar
PDF] Acceptance rates of scholarly peer-reviewed journals: A literature survey | Semantic Scholar

A survey of COVID-19 vaccine acceptance across 23 countries in 2022 | Nature  Medicine
A survey of COVID-19 vaccine acceptance across 23 countries in 2022 | Nature Medicine